<DOC>
	<DOCNO>NCT01261364</DOCNO>
	<brief_summary>Determine antidepressant treatment guide pharmacogenetic algorithm interpretive report improve outcomes compare standard treatment without availability genetic information .</brief_summary>
	<brief_title>Pharmacogenetic-Directed Treatment Major Depression</brief_title>
	<detailed_description>This study design evaluate clinical impact pharmacogenetic ( PGx ) -directed treatment , guide interpretive , algorithmic report Pine Rest outpatient behavioral health clinic . The PGx algorithm utilize study foundation novel method interpret genetic test result report rapidly deliver format provide enhanced guidance psychiatrist selection antidepressant medication</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Diagnosis Major Depressive Disorder ( 296.2 , 296.3 ) Depressive Disorder NOS ( 311.0 ) board certify psychiatrist . The patient refer study treat psychiatrist nurse practitioner approve study investigator make subject referral study . The patient outpatient imminent need inpatient hospitalization medical psychiatric reason . Patient 's baseline 17Item Hamilton Depression ( HAMD17 ) Rating score &gt; 14 . Provide copy physical exam report perform within 6 month prior study enrollment undergo physical exam either personal physician , physician subinvestigator study , studycontracted physician assistant internal medicine . Undergo medical history include review major organ system either treat clinician , subinvestigator physician , studycontracted physician assistant internal medicine . The patient sign study inform consent form . Serious medical illness ( ascertained via inclusion criterion 6 7 , ) . Diagnosis Bipolar Disorder . Diagnosis Schizophrenia Schizoaffective disorder . Evidence history , baseline urine drug screen , and/or psychiatric interview active abuse alcohol and/or drug abuse within 6 month prior study enrollment . Patients occasionally use marijuana may still eligible determined psychiatric interview level use qualify abuse , dependence , addiction . Patients test positive opioids benzodiazepine eligible evidence abuse determine take opioid analgesic benzodiazepine prescribe licensed prescriber medical psychiatric indication . History prior pharmacogenomic testing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>GeneSight</keyword>
	<keyword>Assurex</keyword>
	<keyword>AssureRx</keyword>
</DOC>